Treatment of premature ejaculation with sertralin
dc.authorscopusid | 6701788548 | |
dc.authorscopusid | 7006190678 | |
dc.authorscopusid | 55581880900 | |
dc.authorscopusid | 7801580533 | |
dc.authorscopusid | 24492292800 | |
dc.contributor.author | Balbay M.D. | |
dc.contributor.author | Yildiz M. | |
dc.contributor.author | Salvarci A. | |
dc.contributor.author | Özsan Ö. | |
dc.contributor.author | Özbek E. | |
dc.date.accessioned | 2024-08-04T19:59:22Z | |
dc.date.available | 2024-08-04T19:59:22Z | |
dc.date.issued | 1998 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | To evaluate the efficacy of oral sertralin in the treatment of premature ejaculation, out of 22 patients with premature ejaculation 16 received oral sertralin, 50 mg a day for at least 2 weeks. Four patients were lost to follow-up. Two patients interrupted treatment due to side effects of sertralin. Out of 16 patients who completed at least a two-week period of treatment 14 (87.5%) responded clinically. Clinical response was achieved in the first week of treatment in 11 of 16 responders (68.75%). We conclude that low dose oral sertralin may be useful with a reasonable side effect rate in the treatment of patients suffering from premature ejaculation. | en_US |
dc.identifier.doi | 10.1007/BF02550283 | |
dc.identifier.endpage | 83 | en_US |
dc.identifier.issn | 0301-1623 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 9569117 | en_US |
dc.identifier.scopus | 2-s2.0-0031695161 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 81 | en_US |
dc.identifier.uri | https://doi.org/10.1007/BF02550283 | |
dc.identifier.uri | https://hdl.handle.net/11616/90574 | |
dc.identifier.volume | 30 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Akademiai Kiado Rt. | en_US |
dc.relation.ispartof | International Urology and Nephrology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | sertraline | en_US |
dc.subject | adult | en_US |
dc.subject | anorgasmia | en_US |
dc.subject | appetite disorder | en_US |
dc.subject | article | en_US |
dc.subject | clinical article | en_US |
dc.subject | dose response | en_US |
dc.subject | drug efficacy | en_US |
dc.subject | human | en_US |
dc.subject | male | en_US |
dc.subject | male sexual dysfunction | en_US |
dc.subject | nausea | en_US |
dc.subject | oral drug administration | en_US |
dc.subject | penis erection | en_US |
dc.subject | premature ejaculation | en_US |
dc.subject | sweating | en_US |
dc.subject | vertigo | en_US |
dc.subject | yawning | en_US |
dc.title | Treatment of premature ejaculation with sertralin | en_US |
dc.type | Article | en_US |